Drug Discovery

Scientist using a well plate
#Automated workflows #Cell culture #Drug discovery #In vitro assays #minit #Semarion

Early adopters get access to new microcarrier platform

Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory, has opened the Early Adopter Programme for its SemaCyte Microcarrier Platform. The platform aims to overcome the limitations associated with adherent cell culture and assaying workflows by enabling small colonies of cells to be moved… Read More

#News

#Clinical trial #Clinical trials #Drug development #Drug discovery #Phase I trial

New podcast: DDW Highlights 17 October 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The buzz with week has been around Phase I trials, with new… Read More

#News

amino acids chain
#Drug discovery #Drug targets #Proteomics

Untapping the potential of targeted protein degradation with proteomics

Professor Henrik Daub, Founder and CSO, NEOsphere Biotechnologies looks at the advancements taking place in proteomics and how targeted protein degradation represents a promising approach for developing new treatments for life-threatening diseases.   Advancements in proteomics using mass spectrometry are helping researchers to identify novel, previously undruggable targets and… Read More

#Exclusive Content

#Clinical trial #Clinical trials #Drug development #Drug discovery #Phase I trial

This week in drug discovery (9-13 October)  

News round-up for 9-13 October by DDW Digital Content Editor Diana Spencer. The buzz with week has been around Phase I trials, with new therapies for lung cancer, geographic atrophy, Parkinson’s, sarcopenia and long Covid demonstrating positive early results or entering clinical trials for the first… Read More

#News

Quantum computer
#Drug discovery #Funding #Quantum computing #Start-ups #Wellcome Trust

French start-ups win $40M for quantum drug discovery project

French start-ups Pasqal and Qubit Pharmaceuticals are among the 12 selected performers for the Quantum for Bio programme in consortium with the Unitary Fund. Together with the Unitary Fund, Pasqal and Qubit will receive $4.5 million of the total $40 million awarded through the various milestones… Read More

#Business & Investment #News #Start-up Zone

Active nerve cells
#Drug discovery #Neurodegenerative disorders #Neuroinflammation #Neurology #Neuroscience #Webinar

New online event: Innovative advances in neuroscience

Hosted by DDW and sponsored by ACRO Biosystems, ‘Innovative advances in neuroscience’ will be free to attend on 8 November 2023 at 7AM PDT / 10AM EST / 3PM GMT / 4PM CET. Join this free webinar to learn about innovation taking place… Read More

Webinar date:
#News

#Drug discovery #Drug Discovery 2023 #ELRIG #Events #Life sciences

Meet the industry: Who’s at Drug Discovery 2023?

ELRIG’s Drug Discovery 2023 will be taking place at ACC Liverpool, UK from 18-19 October 2023, focusing on the importance of a diverse life science ecosystem. Megan Thomas caught up with those planning to attend this year. New approaches and thought processes When it comes to… Read More

#Exclusive Content

World Mental Health Day
#Depression #Drug discovery #Major depressive disorder #Mental health #Postpartum depression

World Mental Health Day 2023: Drug discovery breakthroughs

Over recent months, there have been a number of ground-breaking discoveries in drug discovery for mental health conditions. A new class of antidepressants In July 2023, AlzeCure Pharma published the results of a preclinical study supporting the antidepressive effects ACD856, the first in a new class… Read More

#Editor's Choice #News

#Drug development #Drug discovery #Gene therapy #Genetics / genomics #mRNA

New DDW Highlights podcast: 10 October 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  In celebration of the Nobel Prize for Medicine going to two of… Read More

#News

#Artificial intelligence (AI) #Benchling #Drug discovery #Lab automation #Proscia #Webinar

Register now: AI and lab automation webinar

Hosted by DDW and co-sponsored by Benchling and Proscia, “AI and Lab Automation: What are the key benefits and latest innovations?” will be free to attend on 10 October at 7AM PDT / 10AM EST / 3PM BST / 4PM CET. Join this free webinar to learn… Read More

#News

#Drug development #Drug discovery #Gene therapy #Genetics / genomics #mRNA

This week in drug discovery (2-6 October)  

News round-up for 2-6 October by DDW Digital Content Editor Diana Spencer. In celebration of the Nobel Prize for Medicine going to two of the early proponents of mRNA technology for creating therapeutics, Katalin Karikó and Drew Weissman, this week our round-up highlights the importance of… Read More

#News

Cancer research
#Cancer drug targets #Cancer research #DDW Turning Science into Business Summit #Drug discovery #Events #Immunotherapy #Oncology

DDW announces Summit on advances in cancer research

Join DDW’s Megan Thomas and Reece Armstrong with sponsor Taconic Biosciences for the first DDW Turning Science into Business Summit, ‘Cancer research opportunities and advances’, on 16 November at 7AM PDT / 10AM EST / 3PM GMT / 4PM CET. This free 2-hour… Read More

#Cancer Research #News

#AI #Drug discovery #Generative AI #Machine learning

Generative AI and drug discovery: webinar

The webinar ‘Generative AI: Turning drug discovery into a technological pursuit’ supported by Thermo Fisher Scientific and presented by Generate:Biomedicines will be free to attend on 12 October 9am EDT / 2pm BST / 3pm CEST. The webinar, hosted by DDW, will feature the expertise of Adam Root, Vice President,… Read More

#News

#AI / data analytics / healthtech / informatics #Cloud computing #Drug discovery #Webinar

On-demand webinar: A data-driven approach to drug discovery

Watch this new webinar to embark on an in-depth journey through the pivotal Make-Test-Decide Workflow, where collaboration and data-driven decisions play a paramount role in the intricate landscape of drug discovery. This on-demand webinar from Revvity Signals shows how cloud implementation fosters accessibility and collaboration, revolutionising research across locations and… Read More

Webinar date:
Brought to you by Revvity Signals
#News

AI and lab automation
#Artificial intelligence (AI) #Benchling #Drug discovery #Lab automation #Proscia #Webinar

Key benefits and latest innovations in AI and lab automation

Hosted by DDW and co-sponsored by Benchling and Proscia, “AI and Lab Automation: What are the key benefits and latest innovations?” will be free to attend on 10 October at 7AM PDT / 10AM EST / 3PM BST / 4PM CET. Join this free webinar to learn… Read More

#News